newsfilter
← Latest News
GlobeNewswire·

Windtree Announces Publication of Istaroxime Positive Phase 2 SEISMiC B Study

The Phase 2 Istaroxime study was successful in multiple endpoints showing promise for how it may be utilized if approved in its targeted indications Primary endpoint of the study was met of increasing systolic